Anogenital cancers testing in Maybole
Find health labs to test for Anogenital cancers in Maybole and compare all offers by prices and services.
Tests that cover Anogenital cancers
HPV Test
Pap Smear by CityDoc In-Pharmacy Clinic
1094 Argyle Street, Glasgow, G3 8LY, United Kingdom
38.7 km
HPV Test by Glasgow Medical Rooms
211 St Vincent Street, Glasgow, G2 5, United Kingdom
38.7 km
Unverified
A HPV Test costs £300.00
See Details
HPV Test by Superdrug Health Clinic
167 Sauchiehall Street, Glasgow, G2 3ER, United Kingdom
38.7 km
Pap Smear by GP Matters - Private GP Clinic
24 Buckingham Terrace, Glasgow, G12 8ED, United Kingdom
38.7 km
Unverified
A HPV Test costs £250.00
See Details
HPV Test by CityDoc In-Pharmacy Clinic
2 Old Gartloch Road, Glasgow, G69 8EU, United Kingdom
38.7 km
HPV Test by Waterside House
19 Hawthornbank Lane, Edinburgh, EH4 3BH, United Kingdom
71.3 km
Unverified
A HPV Test costs £200.00
See Details
Pap Smear by Chalmers Sexual Health Centre
2A Chalmers Street, Edinburgh, EH3 9, United Kingdom
71.3 km
Pap Smear by Parkside Surgery
120 York Road, Belfast, BT15 3, United Kingdom
72.1 km
HPV Test by Scottish HPV Reference Laboratory (SHPVRL)
51 Little France Crescent, Edinburgh, EH16 4, United Kingdom
71.3 km
HPV Test by Vitalis Health Belfast- Private GP & Health Clinic
58 Howard Street, Belfast, BT1 6PJ, United Kingdom
72.1 km
Unverified
A HPV Test costs £200.00
See Details
Anogenital cancers - symptoms and how to test
Human papillomavirus (HPV) infection is linked to anogenital malignancies, namely to the alpha genus of mucosal HPV types 16 and 1810,11. There is some evidence that beta-genus HPVs contribute to cutaneous SCC, although it is inconclusive. High-risk HPVs account for 3% of all female malignancies and 2% of all male cancers in the United States. The Centers for Disease Control and Prevention report that each year there are around 45,000 new instances of cancer in areas of the body where HPV is often present. HPV is predicted to cause approximately 36,000 of these (CDC). The HPV test screens for the presence of high-risk HPV strains that are associated with an increased risk of developing cervix precancers and malignancies.
